Ma et al. found that LATS2 acts as a classic tumor suppressor in several kinds of cancer, including esophageal squamous cell carcinoma, breast cancer, pancreatic cancer, and endometrial cancer [35,36,37,38]. This evidence concerns the gene LATS2 and breast carcinoma.